AMBROXOL is a mucolytic expectorant. Ambroxol is an active metabolite of bromhexine, and acts to reduce the viscosity of tenacious mucus secretions by fragmentation of long mucopolysaccharide chains, resulting in a productive cough which aids expectoration of liquefied mucoid respiratory secretions, and assists in clearing and maintaining patent bronchioles and alveoli, hence reducing dyspnoea. AMBROXOL enhances the concentrations of chemotherapeutic agents in bronchial secretions to result in a more rapid recovery.
AMBROXOL is indicated to aid in the treatment of catarrhal inflammation of bronchi and the upper respiratory tract in horses and dogs.
Specific indications include:
Chest Infections: acute and chronic bronchopneumonia, catarrhal
rhinitis, strangles, post-viral cough
Uterine Infections: pyometron, mucometron
Ocular Infections: purulent conjunctivitis, hypopion
DOSAGE AND ADMINISTRATION
Horses: 0.3 mg/kg (5mL/100kg) bodyweight twice daily.
Dogs: 0.6 mg/kg (1mL/10 kg) bodyweight twice daily.
Administer AMBROXOL by intravenous injection.
Meat Witholding Period [Horses]: 28 Days